ZENIQUIN TABLETS 100MG

Maa: Australia

Kieli: englanti

Lähde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktiivinen ainesosa:

MARBOFLOXACIN

Saatavilla:

ZOETIS AUSTRALIA PTY LTD

INN (Kansainvälinen yleisnimi):

marbofloxacin(100mg/Tb)

Lääkemuoto:

ORAL TABLET

Koostumus:

MARBOFLOXACIN ANTIBIOTIC Active 100.0 mg/Tb

Kpl paketissa:

50 Tablets

luokka:

VM - Veterinary Medicine

Valmistaja:

ZOETIS AUSTRALIA

Terapeuttinen ryhmä:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Terapeuttinen alue:

ANTIBIOTIC & RELATED

Käyttöaiheet:

BACILLUS SPP. | BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B | CORYNEBACTERIUM SPP. | ENTEROCOCCUS FAECALIS | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF THE SKIN | INFECTIONS OF THE URINARY TRACTS | KLEBSIELLA PNEUMONIAE | PASTEURELLA MULTOCIDA | PROTEUS MIRABILIS | PSEUDOMONAS AERUGINOSA | PSEUDOMONAS SPP. | SOFT TISSUE INFECTIONS | STAPHYLOCOCCUS AUREUS | STAPHYLOCOCCUS INTERMEDIUS | STREPTOCOCCUS SPP. | ABSCESSES | ANAL SACCULITIS | BACTERIAL CANKER | DEEP PYODERMAS | ESCHERICHIA COLI | FOWL CHOLERA | FUNGAL | GINGIVITIS | GRAM NEGATIVE BACTERIA | GRAM POSITIVE BACTERIA | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | INCLUDING SECONDARY INVADERS | KLEBSIELLA SPP. | NOT GROUP A | NOT GROUP B | POST-PARTURIENT INFECTIONS | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | PYODERMA | SEBORRHOEIC DERMATITIS | SEPTICAEMIA | STAPHYLOCOCCUS SPP. | YEAST

Tuoteyhteenveto:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [BACILLUS SPP., BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B, CORYNEBACTERIUM SPP., ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE SKIN, PASTEURELLA MULTOCIDA, SOFT TISSUE INFECTIONS, STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS INTERMEDIUS]; DOG: [BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B, ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE SKIN, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA PNEUMONIAE, PASTEURELLA MULTOCIDA, PROTEUS MIRABILIS, PSEUDOMONAS AERUGINOSA, PSEUDOMONAS SPP., SOFT TISSUE INFECTIONS, STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS SPP.]; For the treatment in dogs of skin, soft tissue and urinary tract infections caused by organisms susceptible to marbofloxacin.

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2022-07-01

Pakkausseloste

LABEL IMAGE PROUDLY SUPPLIED BY
[e-mail]

Valmisteyhteenveto

PRODUCT NAME: ZENIQUIN TABLETS
PAGE: 1 OF 5
This revision issued: September, 2011
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Blend of ingredients (see below). Active ingredient is antibacterial.
TRADE NAME:
ZENIQUIN TABLETS
PRODUCT USE:
Antibacterial preparation used in veterinary applications.
CREATION DATE:
JULY, 2006
THIS VERSION ISSUED:
SEPTEMBER, 2011
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Xn, Harmful. Hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R43, R62, R48/22. May cause sensitisation by skin contact. Possible
risk of impaired fertility.
Harmful: danger of serious damage to health by prolonged exposure if
swallowed.
SAFETY PHRASES:
S20, S22, S28, S36, S53. When using, do not eat or drink. Do not
breathe dust. After contact with
skin, wash immediately with plenty of soap and water. Wear suitable
protective clothing. Avoid exposure - obtain
special instructions before use.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Beige coloured film-coated tablets.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
possible skin sensitiser, possible risk of impaired fertility. A
significant ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product
as it may cause sensiti